We don’t really know, of course. That’s the way it usually works with sweeping reforms. In this case, many businesses seem to believe the law, as upheld by the Supreme Court last week, will increase their costs. But businesses historically have a poor track record of predicting how new laws will affect them. Certainly, in […]
[Read More]

The U.S. Supreme Court has upheld the individual insurance mandate for President Obama’s health care law, which clears the way for the next — and most expensive — round of reforms that will be enacted in 2014. The decision will allow millions of people who currently don’t have insurance to get coverage through state exchanges […]
[Read More]

With the Supreme Court arguments this week, Obamacare’s individual mandate has once again become the primary focus of the health care reform debate. While its constitutionality is in question, the rhetoric around the individual mandate has reached a fever pitch. Constitutionality is a valid question, but it’s also worth remembering that the individual mandate won’t […]
[Read More]

As the Supreme Court begins hearing the second day of arguments over the health care reform law, specifically the constitutionality of requiring individuals to buy insurance, there’s a more fundamental issue that the court won’t consider. I’ve argued for a while now that while I have my issues with the reform law itself, my biggest […]
[Read More]

That whole financial crisis/global recession thing is soooo yesterday. There’s no point in dwelling in the past, especially if you’re an executive who’s been cooling his heels on the pay front for the past two years. After stagnating since 2008, executive pay roared back last year, the Guardian reports. A survey by the corporate governance […]
[Read More]

It’s not surprising that Pfizer would be doing everything it can to blunt the introduction of generic Lipitor, its blockbuster cholesterol-fighting drug. But it’s got some unusual bedfellows in the fight: pharmacy benefit companies. Big benefit managers, like Medco Health Solutions, are telling pharmacists to continue filling prescriptions with the more expensive Lipitor once Pfizer’s […]
[Read More]